Synthesis and Biological Activities of Novel 1,4-Bridged Bis-1,2,4-Triazoles, Bis-1,3,4-Thiadiazoles and Bis-1,3,4-Oxadiazoles
摘要:
The terephthalic acid hydrazide (1) reacted with phenyl / benzyl isothiocyanate 2a,b to yield the corresponding bis-thiosemicarbazides 4a,b, via acid hydrolysis of the intermediate 3 whereas cyclization of 4 gave the bis-1,2,4-triazoles 5,6 and bis-1,3,4-thiadiazoles 7,8. Similarly, compound 1 reacted with phenyl isocyanate 9 to give the bis-semicarbazide 10, which was cyclized to the bis-oxadiazole 11 and/or bis-1,2,4-triazole 12 in POCl3 and NaOH respectively,
Synthesis and Biological Activities of Novel 1,4-Bridged Bis-1,2,4-Triazoles, Bis-1,3,4-Thiadiazoles and Bis-1,3,4-Oxadiazoles
摘要:
The terephthalic acid hydrazide (1) reacted with phenyl / benzyl isothiocyanate 2a,b to yield the corresponding bis-thiosemicarbazides 4a,b, via acid hydrolysis of the intermediate 3 whereas cyclization of 4 gave the bis-1,2,4-triazoles 5,6 and bis-1,3,4-thiadiazoles 7,8. Similarly, compound 1 reacted with phenyl isocyanate 9 to give the bis-semicarbazide 10, which was cyclized to the bis-oxadiazole 11 and/or bis-1,2,4-triazole 12 in POCl3 and NaOH respectively,
SMALL MOLECULE INHIBITORS OF HIV-1 ENTRY AND METHODS OF USE THEREOF
申请人:Dana-Farber Cancer Institute, Inc.
公开号:US20170298056A1
公开(公告)日:2017-10-19
Described herein are small-molecule compounds that specifically inhibit a wide range of HIV-1 isolates without interfering with CD4 or CCR5 binding. Methods of using die compounds for treating or preventing HIV infection are also described.